genOway
Florent Pons has over 13 years of work experience in various roles. Florent is currently the Director of Commercial Operations at genOway, a position they have held since May 2019. Prior to this, Florent worked at Kea & Partners as a Director from March 2015 to April 2019, where they specialized in strategy and transformation consulting for European and international companies. From September 2008 to October 2014, they served as a Manager at Stratorg. Florent also has experience as a Consultant/Intern at Roland Berger - France from May 2007 to July 2007, and as an Auditor/Intern at KPMG Audit - France from October 2006 to February 2007.
Florent Pons attended Janson de Sailly from 1999 to 2004. Florent then pursued a Master in Management degree at ESCP Business School from 2004 to 2008. In 2007 and 2008, Florent also studied at Tongji University. In 2018, they obtained a certification as a Cultural Transformation Tools Practitioner from Barrett Values Centre.
This person is not in any teams
genOway
1 followers
Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research. Based on its core business and leading expertise in custom-designed models, the company invests in cancer research, with a growing catalog of currently over 30 translational models for immuno-oncology and immunotherapy. genOway holds all relevant licenses on patented technologies used for its model creation, including the exclusive license under Merck’s foundational CRISPR/Cas9 patents portfolio, which enables the company to guarantee its clients FTO, freedom to operate. Headquartered in Lyon, France, genOway serves clients in 380 academic institutions and 170 life sciences companies, including 17 of the top 20 pharma.